Up a level |
Number of items: 1.
Flinn, Ian W, Miller, Carole B, Ardeshna, Kirit M, Tetreault, Scott, Assouline, Sarit E, Mayer, Jiri, Merli, Michele, Lunin, Scott D, Pettitt, Andrew R ORCID: 0000-0002-0907-8950, Nagy, Zoltan et al (show 13 more authors)
(2019)
DYNAMO: A Phase II Study of Duvelisib (IPI-145) in Patients With Refractory Indolent Non-Hodgkin Lymphoma.
JOURNAL OF CLINICAL ONCOLOGY, 37 (11).
912-+.